Welcome to our dedicated page for Privia Health Group news (Ticker: PRVA), a resource for investors and traders seeking the latest updates and insights on Privia Health Group stock.
Privia Health Group, Inc. (Nasdaq: PRVA) is a technology-driven physician enablement company that regularly issues detailed updates on its operations, value-based care performance, and network expansion. Its news flow often includes quarterly financial results, guidance updates, and announcements related to Accountable Care Organizations (ACOs) and partnerships with independent physician groups.
Investors following PRVA news can expect recurring earnings releases that highlight metrics such as total revenue, gross profit, operating income, net income, Adjusted EBITDA, Implemented Providers, Value-Based Care Attributed Lives, Practice Collections, Care Margin, and Platform Contribution. The company frequently discusses its performance in the Medicare Shared Savings Program (MSSP) and other value-based arrangements, including aggregate shared savings achieved by its Privia Quality Network ACOs.
Privia Health also uses news releases to announce strategic transactions and geographic expansion. Recent examples include a definitive agreement to acquire an ACO business from Evolent Health, Inc., which serves more than 120,000 attributed lives, and entry into the Arizona market through a partnership with Integrated Medical Services, Inc., a large independent multi-specialty practice. These updates provide insight into how the company is growing its presence across 15 states and the District of Columbia and increasing the number of attributed lives in value-based care arrangements.
In addition, PRVA news may cover governance and board changes, such as the appointment of new directors with technology and cybersecurity expertise. For readers interested in physician enablement, value-based care, and healthcare technology, the Privia Health news feed offers a view into how the company reports its progress, adjusts its full-year guidance, and describes the performance of its physician networks and ACOs over time.
Biote Medical has announced the election of Dr. Mark Cone and Dana Jacoby to its Board of Directors, strengthening its leadership team with over 60 years of combined experience in healthcare and business management. Dr. Cone is the Market President of Privia Health in South Texas, while Jacoby has led nearly $1 billion in healthcare mergers and transactions. Their appointments aim to enhance Biote's growth and address hormone deficiencies affecting over 200 million Americans.
Privia Health Group (Nasdaq: PRVA) reported impressive results for 2020, achieving $86.5 million in shared savings through its Accountable Care Organizations (ACOs) via the Medicare Shared Savings Program (MSSP). The Privia Quality Network served over 121,000 Medicare beneficiaries, demonstrating a commitment to quality care while lowering costs. Key metrics showed that Privia's expenditures were 15% lower than the median MSSP ACO and emergency room utilization was 22% lower. Since 2014, total shared savings exceed $519 million.
Privia Health Group, Inc. (Nasdaq: PRVA) reported strong revenue growth in Q2 2021, with total revenue climbing to $225.8 million, a 23.2% increase year-over-year. However, the company faced significant operating and net losses of $193.2 million and $172.5 million, respectively, mainly due to $202.6 million in non-cash stock compensation expense related to its IPO. Excluding these, non-GAAP adjusted net income increased 69.0% to $10.4 million. The company expects continued growth with increased provider partnerships and attributed lives, revising its full-year guidance upwards.
Privia Health Group (Nasdaq: PRVA) has announced its financial results release for the second quarter ended June 30, 2021, scheduled for August 9, 2021, before market open. The financial results will be available at 7:00 am ET on the company's Investor Relations website. Additionally, a conference call will follow at 8:00 am ET the same day to discuss the results and future outlook. Interested parties can access the call via webcast or by dialing 855-940-5315.
Health Enterprise Partners (HEP) announced five realizations of portfolio companies and a new investment in Kno2, marking its tenth platform investment from HEP III. HEP focuses on founder-financed businesses, having previously invested in Twistle, which enhances patient engagement in healthcare. Health Catalyst (NASDAQ: HCAT) disclosed its acquisition of Twistle, enhancing its data and analytics services. Privia Health (NASDAQ: PRVA) completed a successful IPO, raising approximately $131.7 million. HEP's new investment in Kno2 will support interoperability in healthcare, aiming for better patient information exchange.
Privia Health Group, Inc. (Nasdaq: PRVA) has appointed Dr. Jaewon Ryu to its Board of Directors, expanding the board to nine members. This strategic move aims to leverage Dr. Ryu’s extensive experience in value-based reimbursement and patient care management to support the company's growth across the U.S. Dr. Ryu is currently the President and CEO of Geisinger and has held various leadership roles in healthcare. The board believes his expertise will significantly benefit Privia Health's initiatives in enhancing patient experiences and delivering high-value care.
Privia Health Group, Inc. (Nasdaq: PRVA) will join the Russell 2000 Index after the U.S. market opens on June 28, 2021. This addition follows the company's recent IPO and is expected to enhance awareness, increase stock liquidity, and broaden the shareholder base. The Russell 2000 Index tracks the performance of the 2,000 smallest stocks in the Russell 3000 Index, which comprises the largest U.S. companies. The reconstitution of Russell indexes is significant for investment strategies, with over $10.6 trillion in assets benchmarked to these indexes.
Privia Health Group, Inc. (Nasdaq: PRVA) announces its participation in upcoming investor conferences. On June 3rd at 10:20 am ET, they will present at the William Blair Growth Stock Conference, followed by the Goldman Sachs Global Healthcare Conference on June 10th at 1:20 pm ET. The events will be available via live webcast and on-demand replay, along with accompanying slide presentations. Privia Health focuses on enhancing physician practices and patient experiences through technology and collaboration with health systems and plans.
Privia Health Group, Inc. (Nasdaq: PRVA) reported a Q1 2021 revenue of $213.6 million, a modest increase of 0.3% from the previous year. The company achieved operating income of $7.9 million, up 21.7%, and net income of $5.4 million with an EPS of $0.06, unchanged year-over-year. Practice collections rose 5.1% to $344.1 million, while value-based care attributed lives declined 4.1% to approximately 721,000. The company has provided guidance for FY 2021 with expected revenue growth of 5.3% to 7.7%.
Privia Health Group (Nasdaq: PRVA) announced plans to release its financial results for Q1 2021 on May 27, 2021, after market close. The release will occur at 4:00 pm ET and will be accessible on the Company’s Investor Relations website. Following this, management will host a conference call at 5:00 pm ET to discuss the results and future outlook. Participants can join via webcast or by phone at 855-940-5315, using participant code 1076290.